Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- GOLDMAN D. Agranulocytosis associated with administration of chlorpromazine; report of three cases with description of treatment and recovery. AMA Arch Intern Med. 1955 Oct;96(4):496–499. doi: 10.1001/archinte.1955.00250150070007. [DOI] [PubMed] [Google Scholar]
- ISAACS B., MACARTHUR J. G., TAYLOR R. M. Jaundice in relation to chlorpromazine therapy. Br Med J. 1955 Nov 5;2(4948):1122–1124. doi: 10.1136/bmj.2.4948.1122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MILES A. A., WILHELM D. L. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum. Br J Exp Pathol. 1955 Feb;36(1):71–81. [PMC free article] [PubMed] [Google Scholar]
- ROTSTEIN J., FRICK P. S., SCHIELE B. C. Agranulocytosis associated with chlorpromazine therapy. AMA Arch Intern Med. 1955 Dec;96(6):781–786. doi: 10.1001/archinte.1955.00250170087013. [DOI] [PubMed] [Google Scholar]
- SPECTOR W. G. The role of some higher peptides in inflammation. J Pathol Bacteriol. 1951 Jan;63(1):93–110. doi: 10.1002/path.1700630111. [DOI] [PubMed] [Google Scholar]
- TASKER J. R. Fatal agranulocytosis during treatment with chlorpromazine. Br Med J. 1955 Apr 16;1(4919):950–951. doi: 10.1136/bmj.1.4919.950. [DOI] [PMC free article] [PubMed] [Google Scholar]